| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 8 |
| 1 | ASPIRIN 325 MG | 8 |
| 2 | ASPIRIN 81 MG | 8 |
| 3 | CLOPIDOGREL | 8 |
| 4 | AMLODIPINE | 7 |
| 5 | FUROSEMIDE | 6 |
| 6 | CLOPIDOGREL BISULFATE | 5 |
| 7 | ACETAMINOPHEN | 4 |
| 8 | CEFTRIAXONE | 4 |
| 9 | CEFTRIAXONE SODIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 1 | MEPROBAMATE | 1 | 0.0008 |
| 2 | FAMOTITINE | 2 | 0.0007 |
| 3 | COLLAGENASE SANTYL | 1 | 0.0006 |
| 4 | BISMUTH SUBSALICYLATE | 3 | 0.0005 |
| 5 | APREPITANT | 3 | 0.0004 |
| 6 | PEGFILGRASTIM | 3 | 0.0003 |
| 7 | REMDESIVIR | 3 | 0.0002 |
| 8 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 1 | 0.0002 |
| 9 | VINORELBINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bismuth [EPC] | 2 | 0.0004 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |
| 3 | Insulin [EPC] | 4 | 0.0001 |
| 4 | Bile Acid [EPC] | 1 | 0.0000 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 4 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 8 | 0.0000 |